JP2016065085A5 - - Google Patents

Download PDF

Info

Publication number
JP2016065085A5
JP2016065085A5 JP2015225509A JP2015225509A JP2016065085A5 JP 2016065085 A5 JP2016065085 A5 JP 2016065085A5 JP 2015225509 A JP2015225509 A JP 2015225509A JP 2015225509 A JP2015225509 A JP 2015225509A JP 2016065085 A5 JP2016065085 A5 JP 2016065085A5
Authority
JP
Japan
Prior art keywords
compounds described
therapeutic methods
therapeutic
methods
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015225509A
Other languages
English (en)
Other versions
JP2016065085A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016065085A publication Critical patent/JP2016065085A/ja
Publication of JP2016065085A5 publication Critical patent/JP2016065085A5/ja
Pending legal-status Critical Current

Links

Claims (1)

  1. 本願明細書に記載の化合物を用いる治療方法。
JP2015225509A 2007-05-31 2015-11-18 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン Pending JP2016065085A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94124207P 2007-05-31 2007-05-31
US60/941,242 2007-05-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013239442A Division JP2014062108A (ja) 2007-05-31 2013-11-20 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン

Publications (2)

Publication Number Publication Date
JP2016065085A JP2016065085A (ja) 2016-04-28
JP2016065085A5 true JP2016065085A5 (ja) 2016-06-30

Family

ID=40094167

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010510560A Active JP5420534B2 (ja) 2007-05-31 2008-06-02 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
JP2013239442A Withdrawn JP2014062108A (ja) 2007-05-31 2013-11-20 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
JP2015225509A Pending JP2016065085A (ja) 2007-05-31 2015-11-18 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2010510560A Active JP5420534B2 (ja) 2007-05-31 2008-06-02 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
JP2013239442A Withdrawn JP2014062108A (ja) 2007-05-31 2013-11-20 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン

Country Status (15)

Country Link
US (3) US8669291B2 (ja)
EP (3) EP2154962A4 (ja)
JP (3) JP5420534B2 (ja)
KR (1) KR101581289B1 (ja)
CN (3) CN108178733A (ja)
AU (1) AU2008259841B2 (ja)
BR (1) BRPI0811639A2 (ja)
CA (1) CA2688493C (ja)
HK (1) HK1200438A1 (ja)
IL (1) IL202405A (ja)
MX (1) MX2009012685A (ja)
NZ (1) NZ580429A (ja)
RU (1) RU2470011C2 (ja)
WO (1) WO2008151156A1 (ja)
ZA (1) ZA200907171B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2361862C2 (ru) * 2003-12-29 2009-07-20 Сепракор Инк. Пиррольные и пиразольные ингибиторы daao
CA2614282A1 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
ES2566479T3 (es) 2006-01-06 2016-04-13 Sunovion Pharmaceuticals Inc. Inhibidores de reabsorción de monoamina con base en tetralona
NZ569630A (en) 2006-01-06 2011-09-30 Sepracor Inc Cycloalkylamines as monoamine reuptake inhibitors
DK2013835T3 (en) 2006-03-31 2015-12-14 Sunovion Pharmaceuticals Inc Preparation of chiral amides and AMINES
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
RU2449989C2 (ru) 2006-06-23 2012-05-10 Эбботт Лэборетриз Производные циклопропиламина в качестве модуляторов h3-гистаминового рецептора
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
WO2008151156A1 (en) 2007-05-31 2008-12-11 Sepracor Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
WO2010017418A1 (en) * 2008-08-07 2010-02-11 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
WO2011017634A2 (en) * 2009-08-07 2011-02-10 Sepracore Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
WO2012037258A1 (en) 2010-09-16 2012-03-22 Abbott Laboratories Processes for preparing 1,2-substituted cyclopropyl derivatives
WO2014018563A2 (en) * 2012-07-23 2014-01-30 The Board Of Trustees Of The Leland Stanford Junior University Methods for the treatment of cancer
US9283196B1 (en) * 2013-01-30 2016-03-15 MediSynergics, LLC Cycloalkyl-diamines for CNS disorders
US9126891B2 (en) * 2014-01-29 2015-09-08 MediSynergics, LLC Cycloalkyl-diamines
US9381170B2 (en) * 2013-01-30 2016-07-05 MediSynergics, LLC Cycloalkyl-diamines for neurodegenerative disorders
WO2016008862A1 (de) * 2014-07-18 2016-01-21 Bayer Cropscience Aktiengesellschaft Substituierte vinyl- und alkinyl-cyanocycloalkanole sowie vinyl- und alkinyl-cyanoheterocyclylalkanole als wirkstoffe gegen abiotischen pflanzenstress
AU2017263457B2 (en) * 2016-05-12 2021-07-08 Research Triangle Institute Vinylogous phenethylamines as neurotransmitter releasers
JP2023528545A (ja) 2020-05-29 2023-07-04 テグ-キョンプク メディカル イノベーション ファウンデーション スルホンアミド誘導体およびそれを有効成分とする精神病の予防または治療に使用するための医薬組成物
EP4159726A4 (en) 2020-05-29 2023-11-15 Daegu-Gyeongbuk Medical Innovation Foundation 5-MEMBED HETEROARYL DERIVATIVE WITH AT LEAST ONE N AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MENTAL DISORDERS USING IT AS AN ACTIVE INGREDIENT
JP2023528546A (ja) 2020-05-29 2023-07-04 テグ-キョンプク メディカル イノベーション ファウンデーション カルボキサミド誘導体およびそれを有効成分とする精神病の予防または治療に使用するための医薬組成物

Family Cites Families (160)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE616646A (ja)
DE1124485B (de) 1960-02-12 1962-03-01 Hoechst Ag Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
US3496181A (en) * 1966-10-24 1970-02-17 Upjohn Co 2 - aminocycloalkyl hydroquinones,esters,ethers and n-oxides thereof,and a process for preparing the same
GB1207731A (en) * 1968-05-14 1970-10-07 Reckitt & Sons Ltd Derivatives of pyrrolidine
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3974157A (en) * 1974-03-04 1976-08-10 Pennwalt Corporation 1-(Amino-alkyl)-2-aryl-cyclohexane alcohols and esters
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4287212A (en) * 1976-04-30 1981-09-01 American Hoechst Corporation 2-Aryl-1,2-dialkylcycloalkylamines
JPS6033106B2 (ja) 1977-10-07 1985-08-01 住友化学工業株式会社 カルボン酸エステル、その製造法およびそれを有効成分とする殺虫、殺ダニ剤
ZA817261B (en) 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
KR840002817A (ko) * 1982-02-09 1984-07-21 케네스 엠 사이러스 2-(페닐메틸렌)사이클로알킬아민 및 -아제티딘화합물의 제조방법
US4540690A (en) * 1982-02-09 1985-09-10 The Upjohn Company 2-(Phenylmethylene)cycloalkylamines and -azetidines
JPS58177915A (ja) 1982-04-12 1983-10-18 Green Cross Corp:The 抗血栓剤
EP0152032B1 (en) 1984-02-03 1988-10-26 Olympus Optical Co., Ltd. Calculus crushing apparatus
JPS60172970A (ja) * 1984-02-15 1985-09-06 Shionogi & Co Ltd シス−アゾリルシクロアルカノ−ル誘導体およびその製造法ならびに農業用殺菌剤
CA1244041A (en) 1984-07-30 1988-11-01 Elijah H. Gold Process for the preparation of cis, endo- octahydrocyclopenta¬b|pyrrole-2-carboxylate
DE3431541A1 (de) 1984-08-28 1986-03-06 Hoechst Ag, 6230 Frankfurt Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4738709A (en) 1985-01-10 1988-04-19 Ppg Industries, Inc. Herbicidally active substituted benzisoxazoles
US4751231A (en) 1987-09-16 1988-06-14 Merck & Co., Inc. Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
JPH01172388A (ja) 1987-12-25 1989-07-07 Sumitomo Chem Co Ltd チエノ〔3,2−b〕ピロロ〔2,3−d〕ピロール類およびその製法
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US4981870A (en) 1989-03-07 1991-01-01 Pfizer Inc. Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
JPH0347123A (ja) 1989-05-05 1991-02-28 G D Searle & Co インドール―2―カルボキシレート化合物類を含有するcns疾患治療用組成物
AU654653B2 (en) 1989-05-31 1994-11-17 Pharmacia & Upjohn Company Therapeutically useful 2-aminotetralin derivatives
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
ATE126511T1 (de) 1990-02-02 1995-09-15 Schering Corp 4,5-cycloalkano-3-benzazepin-7-ol-derivate und ihre verwendung.
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
JPH0477476A (ja) 1990-07-19 1992-03-11 Sankyo Co Ltd 抗潰瘍剤
US5086054A (en) 1990-07-31 1992-02-04 Sri International Novel arylcycloalkanepolyalkylamines
JP3007138B2 (ja) 1990-11-27 2000-02-07 ファイザー製薬株式会社 新規なヒドロキサム酸とn―ヒドロキシ尿素誘導体およびそれらの組成物
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
GB9208492D0 (en) 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
JP3457669B2 (ja) 1992-10-28 2003-10-20 富山化学工業株式会社 新規な1,2−ベンゾイソオキサゾール誘導体またはその塩,それらからなる脳保護剤
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
GB9304500D0 (en) 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
ES2081747B1 (es) 1993-09-07 1997-01-16 Esteve Labor Dr Amidas derivadas de tienopirroles, su preparacion y su aplicacion como medicamentos.
GB9321221D0 (en) 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
GB9326284D0 (en) 1993-12-23 1994-02-23 Erba Carlo Spa Pyrrolydenemethyl-derivatives and process for their preparation
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
CN1047384C (zh) 1994-07-28 1999-12-15 北京大学 雷米普利的合成方法
ES2208690T3 (es) 1994-08-30 2004-06-16 Sankyo Company Limited Isoxazol.
US5484763A (en) 1995-02-10 1996-01-16 American Cyanamid Company Substituted benzisoxazole and benzisothiazole herbicidal agents
US5620997A (en) 1995-05-31 1997-04-15 Warner-Lambert Company Isothiazolones
US5859042A (en) 1995-09-27 1999-01-12 Ono Pharmaceutical Co., Ltd. Five membered heterocyclic compounds
ATE239694T1 (de) 1995-10-26 2003-05-15 Mitsubishi Pharma Corp Phenylethanolamin-verbindungen und ihre anwendung als beta3 agonisten, verfahren zu ihrer herstellung und zwischenprodukte ihrer herstellung
DE59709437D1 (de) * 1996-01-31 2003-04-10 Altana Pharma Ag Neue phenanthridine
DE19711785A1 (de) 1997-03-21 1998-09-24 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
US6503582B1 (en) 1997-08-19 2003-01-07 Mattel, Inc. Fluid-swellable composition, device and method for using the same
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
AU9275498A (en) 1997-10-03 1999-04-27 Chirotech Technology Limited Chiral amines
GB9803228D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
WO1999048868A2 (en) 1998-03-26 1999-09-30 Sugen, Inc. Heterocyclic classes of compounds for the modulating tyrosine protein kinase
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6632836B1 (en) 1998-10-30 2003-10-14 Merck & Co., Inc. Carbocyclic potassium channel inhibitors
IL142778A0 (en) * 1998-12-02 2002-03-10 Darwin Discovery Ltd Therapeutic product and its use
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
DE19915601A1 (de) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
FR2795733B1 (fr) 1999-06-30 2001-09-07 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
EP1088824B1 (en) 1999-09-30 2004-01-07 Pfizer Products Inc. Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
EP1391460A1 (en) 1999-09-30 2004-02-25 Pfizer Products Inc. Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors
ATE285821T1 (de) 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
WO2001042203A1 (en) * 1999-12-08 2001-06-14 Eli Lilly And Company Cyclopentyl sulfonamide derivatives
DE19960917A1 (de) 1999-12-17 2001-06-21 Bayer Ag Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen
DE10000312A1 (de) 2000-01-05 2001-07-12 Gruenenthal Gmbh Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
US6632417B2 (en) 2000-03-07 2003-10-14 Chevron U.S.A. Inc. Process for preparing zeolites
JP2001247462A (ja) 2000-03-07 2001-09-11 Otsuka Pharmaceut Co Ltd ウレアーゼ阻害剤
EP1136071A3 (en) 2000-03-22 2003-03-26 Pfizer Products Inc. Use of glycogen phosphorylase inhibitors
US6632948B2 (en) 2000-04-19 2003-10-14 Kaneka Corporation Azetidine derivative and process for preparation thereof
GB0012214D0 (en) 2000-05-19 2000-07-12 Merck Sharp & Dohme Therapeutic agents
AU2001280461A1 (en) 2000-08-04 2002-02-18 Eli Lilly And Company Substituted pyrrole compounds and their use as spla2 inhibitors
GB0021831D0 (en) 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
DE10049481A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte C-Cyclohexylmethylamin-Derivate
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
CA2424987A1 (en) 2000-10-06 2002-04-18 Smithkline Beecham Corporation Methods of agonizing and antagonizing fabk
AU2002212959A1 (en) * 2000-10-13 2002-04-29 Eli Lilly And Company Cycloalkylfluorosulfonamide derivatives
SE0003810D0 (sv) 2000-10-20 2000-10-20 Pharmacia Ab Novel compounds their use and preparations
TWI283575B (en) 2000-10-31 2007-07-11 Eisai Co Ltd Medicinal compositions for concomitant use as anticancer agent
DE10063992A1 (de) 2000-12-21 2002-07-04 Max Planck Gesellschaft Tryptophan-Analoga in Proteinen, Peptiden und peptidischen Leitstrukturen
US6372919B1 (en) 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
US20020123490A1 (en) 2001-03-01 2002-09-05 Pfizer Inc. Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis
US7365205B2 (en) 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
GB0115602D0 (en) 2001-06-26 2001-08-15 Syngenta Participations Ag Organic compounds
DE10132747A1 (de) * 2001-07-05 2003-01-23 Gruenenthal Gmbh Substituierte 1-Aryl-but-3-enylamin- und 1-Aryl-but-2-enylaminverbindungen
US6603000B2 (en) 2001-07-11 2003-08-05 Boehringer Ingelheim Pharmaceuticals, Inc. Synthesis for heteroarylamine compounds
BR0211565A (pt) 2001-08-09 2004-06-29 Daiichi Seiyaku Co Derivados de diamina
US7045543B2 (en) 2001-11-05 2006-05-16 Enzrel Inc. Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
US20030162825A1 (en) 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
WO2003048113A1 (en) 2001-11-30 2003-06-12 Sepracor Inc. Tramadol analogs and uses thereof
DE10164581A1 (de) * 2001-12-14 2003-06-26 Gruenenthal Gmbh Substituierte Aminoalkohole
DE10161809A1 (de) 2001-12-14 2003-06-26 Gruenenthal Gmbh Arzneimittel enthaltend N,N'-disubstituierte Piperazin-Verbindungen
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
US20030158078A1 (en) * 2002-02-11 2003-08-21 Jeanne Chang Detergent composition comprising a block copolymer
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
US6995144B2 (en) 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
JPWO2003091213A1 (ja) 2002-04-25 2005-09-02 アステラス製薬株式会社 新規なアミド誘導体又はその塩
WO2003092670A1 (en) 2002-05-03 2003-11-13 Warner-Lambert Company Llc Bombesin antagonists
FR2841487B1 (fr) 2002-06-26 2004-08-20 Solystic Procede de detection de plis simples et de plis en prise multiple dans une installation de tri postal
US20050182131A1 (en) * 2002-07-19 2005-08-18 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
DE10233048A1 (de) * 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
AU2003252299A1 (en) 2002-07-31 2004-02-16 Eisai Co., Ltd. Novel physiologically active substance
US7537891B2 (en) 2002-08-27 2009-05-26 Bristol-Myers Squibb Company Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
DE60305052T2 (de) 2002-09-06 2006-12-21 Janssen Pharmaceutica N.V. Thienopyrrolyl und furanopyrrolyl verbindungen und deren verwendung als histamin h4 rezeptor liganden
JP4610336B2 (ja) 2002-09-16 2011-01-12 セプラコール インク. トランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−1−ナフタレンアミン及びそのホルムアミドによる中枢神経系障害の治療
US20040087661A1 (en) 2002-09-16 2004-05-06 Sepracor, Inc. Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine
TW200418838A (en) * 2002-09-18 2004-10-01 Bristol Myers Squibb Co Compounds for the treatment of premature ejaculation
MXPA05003550A (es) 2002-10-03 2006-01-24 Cypress Bioscience Inc Incremento de dosificacion y dosis diaria dividida de anti-depresivos para tratar padecimientos neurologicos.
GB0222909D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
US20040097554A1 (en) 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
AU2003274462A1 (en) 2002-11-07 2004-06-07 Pfizer Products Inc. N-(indole-2-carbonyl) amides as anti-diabetic agents
CN100434420C (zh) 2003-01-31 2008-11-19 株式会社三和化学研究所 阻碍二肽基肽酶ⅳ的化合物
WO2004089470A2 (en) 2003-04-11 2004-10-21 Novo Nordisk A/S New amide derivatives and pharmaceutical use thereof
EP1633709A1 (en) 2003-04-30 2006-03-15 Pfizer Products Inc. Anti-diabetic agents
WO2004113345A1 (ja) 2003-06-20 2004-12-29 Japan Tobacco Inc. 縮合ピロール化合物及びその医薬用途
PT1362864E (pt) 2003-06-30 2007-07-23 Servier Lab Novo processo de síntese do perindopril e dos seus sais aceitáveis do ponto de vista farmacêutico
AU2004255863A1 (en) 2003-07-07 2005-01-20 Ciba Specialty Chemicals Holding Inc. Process for the preparation of furopyrroles
KR20130081319A (ko) 2003-07-29 2013-07-16 시그너쳐 알 앤드 디 홀딩스, 엘엘씨 아미노산 프로드럭
GB0318463D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0319759D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
WO2005020986A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
GB0320422D0 (en) 2003-08-30 2003-10-01 Astrazeneca Ab Chemical compounds
ES2297502T3 (es) 2003-10-23 2008-05-01 F. Hoffmann-La Roche Ag Derivados de triaza-espiropiperidinas para uso como inhibidores de glyt-1 en el tratamiento de trastornos neurologicos y neuropsiquiatricos.
US7396940B2 (en) 2003-10-23 2008-07-08 Hoffmann-La Roche Inc. Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid
SI1420028T1 (sl) 2003-11-19 2007-06-30 Servier Lab Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
KR20060128978A (ko) 2003-12-29 2006-12-14 세프라코 아이엔시. 벤조[디]이속사졸­3­올 디에이에이오 억제제
RU2361862C2 (ru) 2003-12-29 2009-07-20 Сепракор Инк. Пиррольные и пиразольные ингибиторы daao
CA2559105A1 (en) 2004-03-16 2005-09-29 Janssen Pharmaceutica N.V. Benzisoxazoles
ATE472540T1 (de) 2004-05-07 2010-07-15 Warner Lambert Co Als h3-liganden geeignete 3- oder 4- monosubstituierte phenol- und thiophenol-derivate
MXPA06013270A (es) * 2004-05-14 2007-04-23 Johnson & Johnson Compuestos de opioide carboxamido.
CN1956975A (zh) * 2004-05-21 2007-05-02 默克公司 趋化因子受体活性的氨基环戊基杂环和碳环调节剂
KR101128065B1 (ko) 2004-05-26 2012-04-12 에자이 알앤드디 매니지먼트 가부시키가이샤 신나미드 화합물
WO2005123677A1 (en) 2004-06-16 2005-12-29 Actelion Pharmaceuticals Ltd 4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
RU2376309C2 (ru) 2004-07-01 2009-12-20 Асубио Фарма Ко., Лтд. Производное тиенопиразола, имеющее ингибирующую фосфодиэстеразу 7 (pde 7) активность
US7276631B2 (en) * 2004-07-20 2007-10-02 Bristol-Myers Squibb Company Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
JO2629B1 (en) 2004-08-19 2012-06-24 افينتيس فارما سوتيكالز انك Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
US7411093B2 (en) * 2004-12-20 2008-08-12 Hoffman-La Roche Inc. Aminocycloalkanes as DPP-IV inhibitors
US20090069384A1 (en) 2005-01-19 2009-03-12 Biolipox Ab Thienopyrroles useful in the treatment of inflammation
CN100391945C (zh) 2005-05-31 2008-06-04 浙江大学 一种s-(-)-吲哚啉-2-羧酸的合成方法
US20090306169A1 (en) 2005-10-06 2009-12-10 Brandish Philip E Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
NZ569630A (en) 2006-01-06 2011-09-30 Sepracor Inc Cycloalkylamines as monoamine reuptake inhibitors
ES2566479T3 (es) 2006-01-06 2016-04-13 Sunovion Pharmaceuticals Inc. Inhibidores de reabsorción de monoamina con base en tetralona
DK2013835T3 (en) 2006-03-31 2015-12-14 Sunovion Pharmaceuticals Inc Preparation of chiral amides and AMINES
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US20080058395A1 (en) 2006-06-30 2008-03-06 Sepracor Inc. Fused heterocyclic inhibitors of D-amino acid oxidase
US7579370B2 (en) 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
KR20090024823A (ko) 2006-06-30 2009-03-09 세프라코 아이엔시. D-아미노산 옥시다제의 융합된 헤테로사이클 억제제
CN1962656A (zh) 2006-11-29 2007-05-16 沈阳药科大学 吲哚美辛5-氟尿嘧啶甲酯药用化合物及其制剂和制备方法
UY30829A1 (es) * 2006-12-21 2008-07-31 Abbott Lab Compuestos agonistas y antagonistas del receptor de esfinfosina-1-fosfato
US20090099248A1 (en) 2007-01-18 2009-04-16 Sepracor Inc. Inhibitors of d-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
WO2008151156A1 (en) * 2007-05-31 2008-12-11 Sepracor Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
WO2010017418A1 (en) 2008-08-07 2010-02-11 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase

Similar Documents

Publication Publication Date Title
JP2016028092A5 (ja)
JP2016065085A5 (ja)
JP2016028081A5 (ja)
JP2016196495A5 (ja)
JP2017214405A5 (ja)
JP2016502162A5 (ja)
JP2017137500A5 (ja)
DK3587417T3 (da) 1,3-thiazol-2-yl-substituerede benzamider
JP2018533683A5 (ja)
BR112018005409A2 (pt) terapêutica de glicodirecionamento.
KR20180084876A (ko) 내플라즈마성 부재
DK3402782T3 (da) 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decanderivater
JP2015173751A5 (ja)
UY4430S (es) “motocicleta”.
JP2019505548A5 (ja)
FI20165332A (fi) Valaisinjärjestely
JP2015016294A5 (ja)
JP2016053220A5 (ja)
JP2017528459A5 (ja)
JP2015200574A5 (ja)
JP2016047837A5 (ja)
JP2015043197A5 (ja)
JP2017149782A5 (ja)
DK3795130T3 (da) Terapiapparat.
JP2016054715A5 (ja)